Investors

News Release

<< Back
Codexis to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on February 27, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 14, 2013-- Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals, today announced it will host a live conference call and audio webcast on Wednesday, February 27, 2013 at 4:30 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2012 financial results for the period ended December 31, 2012. The call and webcast will follow the release of fourth quarter and fiscal year financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.

What:   Codexis' Fourth Quarter and Fiscal Year 2012 Financial Results
 

Date:

Wednesday, February 27, 2013
 

Time:

4:30 p.m. ET
 

Live Call:

US: 866-804-6924
International: 857-350-1670
Passcode: 10379003
 

Webcast:

www.codexis.com

 

Replay:

US: 888-286-8010
International: 617-801-6888
Passcode: 11023504
 

About Codexis, Inc.

Codexis, Inc. is a developer of world-leading enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals. Codexis' product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Arch Pharmalabs. For more information, see www.codexis.com.

Source: Codexis, Inc.

Stern Investor Relations
Paul Cox, 212-362-1200
ir@codexis.com

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share Page

X
| E-mail Alerts E-mail Alerts | IR Contacts Contacts | Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSISTM

We are an industrial biotechnology company delivering real business results through biobased innovation in chemicals, fuels, pharmaceuticals, consumer, and industrial products.

PHARMACEUTICAL ENZYMES


Supporting faster, cleaner, more efficient pharmaceutical manufacturing processes

Codexis delivers a range of chemicals at kilogram to multi-ton scale, through a partnered manufacturing network

CODEXIS

WHAT WE DO


Codexis delivers revolutionary biocatalytic routes that no one else can


CODEXIS

MEDIA CENTER


Visit our Media Center for the latest product information, videos, imagery, technical papers and press information.


CAREERS AT CODEXIS

An opportunity to make a difference.

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information
for the investment community

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue